Holding(s) in Company

Rentokil Initial PLC
03 March 2004


                                  SCHEDULE 10

                   NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company

Rentokil Initial plc

2. Name of shareholder having a major interest

Franklin Resources, Inc. (and affiliates)

3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18

IN RESPECT OF HOLDINGS OF SHAREHOLDERS REFERRED TO IN 2 ABOVE.

4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Bank of New York Europe Ltd, London            20,830
Bank of New York, London                    3,406,900
JP Morgan/Chase, London                    66,626,601
Citibank Nominees Ltd, London               1,093,030
Clydesdale Bank plc, London                 3,243,400
Euroclear Bruxelles BIC Mgt, London            23,200
HSBC Bank, London                             571,970
Mellon Bank, London                         6,615,360
Merrill Lynch, London                       1,637,300
Northern Trust Company, London              2,278,007
Royal Trust Corp of Canada, London          2,849,970
State Street Nominees Ltd, London           9,963,430

5. Number of shares / amount of stock acquired
   24,400,557

6. Percentage of issued class
   1.33%

7. Number of shares / amount of stock disposed
N/A

8. Percentage of issued class
N/A

9. Class of security
Ordinary 1p

10. Date of transaction
2 March 2004

11. Date company informed
3 March 2004

12. Total holding following this notification
    98,329,998

13. Total percentage holding of issued class following this notification
    5.389%

14. Any additional information
No

15. Name of contact and telephone number for queries
Paul Griffiths 01342 830332
16. Name and signature of authorised company official responsible for making
this notification

Date of notification
3 March 2004
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.



                      This information is provided by RNS
            The company news service from the London Stock Exchange